OptiMedica, Topcon in EU PASCAL deal:
This article was originally published in Clinica
Ophthalmic technology developer OptiMedica has granted Topcon Europe Medical exclusive rights to distribute its PASCAL (Pattern Scan Laser) photocoagulator product within key European markets. According to OptiMedica (Santa Clara, California), the PASCAL is designed to optimise the treatment of eye disease by applying a predetermined pattern array of up to 56 laser spots to the retina with 0.6 seconds. Rotterdam, The Netherlands-based Topcon Europe Medical, the European headquarters of Japanese multinational Topcon, distributes its products to several European countries, including France, Germany, Sweden and the UK.
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.